Is Schwartz-Jampel syndrome hereditary?

Schwartz-Jampel syndrome is a hereditary genetic condition, meaning it is passed from parents to children through specific changes in their DNA. It follows an autosomal recessive inheritance pattern, which means an individual must inherit two copies of the mutated gene—one from each parent—to manifest the disorder.

Is Schwartz-Jampel syndrome hereditary?

Yes, Schwartz-Jampel syndrome is strictly hereditary. It is classified as an autosomal recessive disorder caused by mutations in the HSPG2 gene. This gene provides instructions for producing perlecan, a protein essential for the structural integrity of cartilage and the proper function of the neuromuscular junction. Because it is recessive, parents of an affected child are typically asymptomatic carriers who each carry one mutated copy of the gene but do not show signs of Schwartz-Jampel syndrome themselves.

What is the risk of passing Schwartz-Jampel syndrome to children?

Because Schwartz-Jampel syndrome follows an autosomal recessive inheritance pattern, the risk for two carrier parents having an affected child is 25% with each pregnancy. There is a 50% chance that the child will be an asymptomatic carrier like the parents, and a 25% chance that the child will inherit two normal copies of the gene. De novo (spontaneous) mutations in Schwartz-Jampel syndrome are extremely rare; the overwhelming majority of cases are inherited from parents who are both carriers of the HSPG2 mutation.

How is genetic testing used for diagnosis and family planning?

Genetic testing is the gold standard for confirming a diagnosis of Schwartz-Jampel syndrome. By performing molecular genetic testing (typically through sequencing the HSPG2 gene), clinicians can identify the specific pathogenic variants involved. If a family has a history of the condition, genetic counseling is highly recommended. Counselors help families understand the following options:

• Carrier Testing: Siblings or extended family members of an affected individual can be tested to determine if they are carriers of the HSPG2 mutation.


• Prenatal Diagnosis: For couples who are known carriers, prenatal testing via chorionic villus sampling (CVS) or amniocentesis can determine if the fetus is affected.


• Preimplantation Genetic Testing (PGT): Couples may choose to undergo IVF with PGT to select embryos that do not carry the specific mutations associated with Schwartz-Jampel syndrome.

Why is genetic counseling essential for this condition?

Navigating a diagnosis of Schwartz-Jampel syndrome involves complex medical and emotional decisions. A clinical geneticist or counselor provides essential support by interpreting test results, calculating recurrence risks, and discussing the variability of the clinical presentation, which can range from mild to severe skeletal and muscular involvement. Because 16 people with Schwartz-Jampel syndrome have already connected through the DiseaseMaps.org community, families can find significant value in speaking with others who have navigated the genetic testing and family planning process firsthand.

Next steps

• Consult with a clinical geneticist to confirm a diagnosis through molecular HSPG2 gene sequencing.


• Schedule a session with a certified genetic counselor to discuss family planning and recurrence risks.


• Connect with the 16 community members on DiseaseMaps.org to share experiences and supportive resources.


• Reach out to the NIH Genetic and Rare Diseases (GARD) Information Center for up-to-date clinical trial information.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Schwartz-Jampel syndrome.


• Orphanet: Schwartz-Jampel syndrome (ORPHA:3125).


• OMIM (Online Mendelian Inheritance in Man): Schwartz-Jampel syndrome type 1 (#255800).


• National Library of Medicine (PubMed): Literature review on HSPG2-related skeletal dysplasias.